Wieser; Josef
Patent Applications and Registrations
Patent applications and USPTO patent grants for Wieser; Josef.The latest application filed is for "novel crystalline forms of ceftaroline fosamil".
Company Profile
0.23.32
- Wieser; Josef - Polling AT
- Wieser; Josef - Kundl AT
- Wieser, Josef - Kufstein AT
Patent Activity
| Patent | Date |
|---|---|
| Process for preparing ceftaroline fosamil Grant RE47,787 - Sturm , et al. Dec | 2019-12-31 |
| Crystalline forms of ceftaroline fosamil Grant 9,534,004 - Wieser , et al. January 3, 2 | 2017-01-03 |
| Process for preparing ceftaroline fosamil Grant 9,481,698 - Sturm , et al. November 1, 2 | 2016-11-01 |
| Crystalline sodium salt of an HIV integrase inhibitor Grant 9,458,146 - Blatter , et al. October 4, 2 | 2016-10-04 |
| Acetone solvate of ivabradine hydrochloride Grant 9,440,924 - Wieser , et al. September 13, 2 | 2016-09-13 |
| Novel Crystalline Forms Of Ceftaroline Fosamil App 20160200750 - Wieser; Josef ; et al. | 2016-07-14 |
| Novel Process For Preparing Ceftaroline Fosamil App 20160046655 - Sturm; Hubert ; et al. | 2016-02-18 |
| Crystal forms of saxagliptin Grant 9,260,389 - Pichler , et al. February 16, 2 | 2016-02-16 |
| Acetone Solvate Of Ivabradine Hydrochloride App 20140336179 - Wieser; Josef ; et al. | 2014-11-13 |
| Crystal Forms Of Saxagliptin App 20140200252 - Pichler; Arthur ; et al. | 2014-07-17 |
| Crystalline Sodium Salt Of An Hiv Integrase Inhibitor App 20140135353 - Blatter; Fritz ; et al. | 2014-05-15 |
| Pharmaceutical compositions containing a crystalline form of posaconazole Grant 8,563,555 - Wieser , et al. October 22, 2 | 2013-10-22 |
| Crystalline form C of tigecycline dihydrochloride and methods for its preparation Grant 8,513,224 - Hotter , et al. August 20, 2 | 2013-08-20 |
| Crystalline form of an organic compound Grant 8,455,639 - Ludescher , et al. June 4, 2 | 2013-06-04 |
| Crystalline form of posaconazole Grant 8,435,998 - Wieser , et al. May 7, 2 | 2013-05-07 |
| Crystalline Forms Of Tigecycline Hydrochloride App 20130012481 - Wieser; Josef ; et al. | 2013-01-10 |
| Crystalline forms of tigecycline hydrochloride Grant 8,252,946 - Wieser , et al. August 28, 2 | 2012-08-28 |
| Crystalline Form Of Posaconazole App 20120101277 - Wieser; Josef ; et al. | 2012-04-26 |
| Crystal Forms Of Saxagliptin App 20120088808 - Pichler; Arthur ; et al. | 2012-04-12 |
| Crystalline Form C Of Tigecycline Dihydrochloride And Methods For Its Preparation App 20120022025 - Hotter; Andreas ; et al. | 2012-01-26 |
| Crystalline Form Of An Organic Compound App 20110306764 - Ludescher; Johannes ; et al. | 2011-12-15 |
| Polymorphic forms of aripiprazole and method Grant 8,008,490 - Wieser , et al. August 30, 2 | 2011-08-30 |
| Antibiotic Compounds App 20110124893 - Decristoforo; Martin ; et al. | 2011-05-26 |
| Crystalline Forms Of Tigecycline Hydrochloride App 20110105772 - Wieser; Josef ; et al. | 2011-05-05 |
| Pharmaceutical Compositions Containing A Crystalline Form Of Posaconazole App 20110105525 - Wieser; Josef ; et al. | 2011-05-05 |
| A Crystalline Form Of Posaconazole App 20110065722 - Wieser; Josef ; et al. | 2011-03-17 |
| Organic Compounds App 20110015191 - Ludescher; Johannes ; et al. | 2011-01-20 |
| Novel Solvate App 20100256402 - Hotter; Andreas ; et al. | 2010-10-07 |
| Method For Salt Preparation App 20100204470 - Wieser; Josef ; et al. | 2010-08-12 |
| Crystalline Solid Forms App 20100160264 - Wieser; Josef ; et al. | 2010-06-24 |
| Amorphous Form Of Cinacalcet App 20090258949 - Ludescher; Johannes ; et al. | 2009-10-15 |
| Crystalline Form Of Cinacalcet App 20090197970 - Ludescher; Johannes ; et al. | 2009-08-06 |
| Cephalosporins Grant 7,485,632 - Ascher , et al. February 3, 2 | 2009-02-03 |
| Organic Compounds App 20080132518 - Wieser; Josef ; et al. | 2008-06-05 |
| Process for preparing polymorphic form II of sertraline hydrochloride Grant 7,253,320 - Ludescher , et al. August 7, 2 | 2007-08-07 |
| Process for preparing polymorphic form II of sertraline hydrochloride App 20060229472 - Ludescher; Johannes ; et al. | 2006-10-12 |
| Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates App 20060223789 - Ascher; Gerd ; et al. | 2006-10-05 |
| Cephalosporins App 20050234233 - Ascher, Gerd ; et al. | 2005-10-20 |
| Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates App 20040132709 - Ascher, Gerd ; et al. | 2004-07-08 |
| Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates Grant 6,693,095 - Ascher , et al. February 17, 2 | 2004-02-17 |
| Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates App 20030114665 - Ascher, Gerd ; et al. | 2003-06-19 |
| Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates App 20020115852 - Ascher, Gerd ; et al. | 2002-08-22 |
| Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates App 20020091252 - Ascher, Gerd ; et al. | 2002-07-11 |
| Process for the production of 3-vinyl cephalosporins App 20010007029 - Wieser, Josef ; et al. | 2001-07-05 |
| Cephalosporin synthesis Grant 6,063,917 - Ascher , et al. May 16, 2 | 2000-05-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 